Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
Nvidia Corp. NVDA, +4.69% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc....
Nvidia Corp. NVDA, +4.69% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc....
The Russell 2000 Index soared 12% in December, which might reflect investors’ exuberance about the state of the U.S. economy...
“Drugs from Canada” is a policy that won’t work. And a political soundbite that won’t die. As H.L. Mencken presciently...
“It’s time for the Biden administration to nix this misguided IP waiver once and for all. ” Several countries are...
Investors have such high hopes for popular weight-loss medications like Wegovy and Ozempic, the wonder drugs have sent shock waves...
Shares of Walgreens Boots Alliance Inc. WBA, -4.05% rallied 3.1% in premarket trading Thursday, after the drugstore chain and healthcare...
Novo Nordisk has entered research collaboration agreements with Omega Therapeutics Inc. and Cellarity Inc. on new treatments for obesity management,...
Losing weight is one of the top New Year’s resolutions that people make year after year, and with good reason....
Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission. The Irvine, Calif.-based...
Moderna Inc.’s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer upgraded the stock to the equivalent...